Drawing for MAXORPTION

USPTO serial 79407494

MAXORPTION

Reviewed by CopyMark Law Group

Reg. 8081611Status 700Registered
Filing date
Status date
Registration date
Dec 30, 2025
Examiner
COHEN, ROBERT ANDREW
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MAXORPTION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael F. Swartz

Michael F. Swartz Egbert, McDaniel & Swartz, PLLC1001 Texas Ave., Suite 1250Houston, TX 77002United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations containing omega 3 for treatment of cardiovascular diseases, cognitive decline, and inflammatory disorders; dietetic foods for medical use containing oils rich in EPA and DHA for treating dyslipidemia, metabolic syndrome, and neurodevelopmental disorders; nutritional supplements for human consumption for medical use containing oils rich in EPA and DHA that are of marine or microalgae origin for treating cardiovascular and metabolic disorders namely hypertriglyceridemia, metabolic syndrome, and type 2 diabetes, neurological and cognitive decline namely Alzheimer's disease and mild cognitive impairment, mood and psychiatric disorders namely depression and anxiety, inflammatory and autoimmune conditions namely rheumatoid arthritis and inflammatory bowel disease, and ophthalmic disorders namely dry eye syndrome and age-related macular degeneration; ophthalmic preparations containing omega-3; food supplements for medical use containing oils rich in EPA and DHA that are of marine or microalgae origin for treating cardiovascular diseases namely hypertriglyceridemia and atherosclerosis, neurodegenerative disorders namely Alzheimer's disease and cognitive decline, psychiatric conditions namely depression and anxiety, inflammatory and autoimmune diseases namely rheumatoid arthritis, and for supporting maternal and infant health namely healthy pregnancy, reduction of risk of preterm birth, optimal fetal brain and retinal development, and post-partum mental health; food supplements for specialized nutrition, infant nutrition; Nutraceuticals containing oils rich in EPA and DHA, targeting the microbiota for treating inflammatory bowel disease, irritable bowel syndrome and metabolic inflammation and intestinal dysbiosis; Nutritional dietetic food additives for medical, paramedical or pharmaceutical use in the nature of natural food extracts derived from fish; food supplements containing omega-3; food supplements derived from microalgae or marine oilsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 23, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 8, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 7, 2026FIMPFINAL DISPOSITION PROCESSED—
Apr 9, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 30, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 23, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 23, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 30, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 30, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 14, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 11, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 11, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 5, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 14, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 16, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 16, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 16, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 5, 2025RFNTREFUSAL PROCESSED BY IB—
Mar 17, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 17, 2025RFRRREFUSAL PROCESSED BY MPU—
Feb 9, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 7, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 4, 2025DOCKASSIGNED TO EXAMINER—
Oct 25, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 25, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 24, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance